Yes very interesting after the constant sell downs.Wonder if...

Yes very interesting after the constant sell downs.
Wonder if there's news due? Wearable seems miles away, what's due is their decision whether to convert their holding in Inhealth to 50.5% by 1st July.

I think you and a few others were here during their Inhealth pump that resulted in bad sentiment with investors and performance shares given to the CEO. What are people's thought here? Will them taking the 50.5% pump the SP back up after finally revealing the big GEMDC? Or investors learnt their mistake and don't want to get burnt again?

Personally i rather them to get Inhealth to pay back the AUD$4.5mil convertible note which would allow them to avoid any CR well after their wearable strategy is commercialized. Also note, CDX only paid up to Tranche 2 for 41.33%. To get to 50.5% they'll still need to pay around 3x annual revenue of Inhealth. Last update on Inhealth's revenue were tracking approx $1m, so assuming after this big GEMDC deal lets say $2-$3mil.
That means CDX has to pay $6-$9mil for the 9.47% to get to 50.5%. And we don't even know whether Inhealth is breaking even or not...